In addition to indirect key strategies (e.g., reduction of hyperglycemia), increasing evidence suggests that erythropoietin (EPO), independent from its hematopoietic effect, may be protective for several tissues, including the heart, brain, and kidney, which may be useful in the prevention of renal disease [17]. This evidence concerns the gene EPO and Hyperglycemia.